Publication | Open Access
Transient Host Range Selection for Genetic Engineering of Modified Vaccinia Virus Ankara
84
Citations
15
References
2000
Year
Viral ReplicationSynthetic VirologyGeneticsImmunologyStrain SelectionMva Deletion MutantsViral EvolutionVirus GeneViral GeneticsVirologyVirus ClassificationRecombinant MvaGene ExpressionCell BiologyVaccinationPathogenesisGenetic EngineeringMva GenomeGene VectorMicrobiologyMedicineViral ImmunityGenome Editing
Recombinant vaccinia viruses are extremely valuable tools for research in molecular biology and immunology. The extension of vaccinia vector technology to replication-deficient and safety-tested virus strains such as modified vaccinia virus Ankara (MVA) have made this versatile eukaryotic expression system even more attractive for basic and clinical research. Here, we report on easily obtaining recombinant MVA using stringent growth selection on rabbit kidney RK-13 cells. We describe the construction and use of new MVA vector plasmids that carry an expression cassette of the vaccinia virus host range gene, K1L, as a transient selectable marker. These plasmids allow either stable insertion of additional recombinant genes into the MVA genome or precisely targeted mutagenesis of MVA genomic sequences. Repetitive DNA sequences flanking the K1L gene were designed to remove the marker gene from the viral genome by homologous recombination under nonselective growth conditions. The convenience of this new selection technique is demonstrated by isolating MVA recombinants that produce green fluorescent protein and by generating MVA deletion mutants.
| Year | Citations | |
|---|---|---|
1984 | 649 | |
1998 | 647 | |
1992 | 599 | |
1991 | 467 | |
1997 | 397 | |
1994 | 288 | |
1989 | 151 | |
Induction of a Mucosal Cytotoxic T-Lymphocyte Response by Intrarectal Immunization with a Replication-Deficient Recombinant Vaccinia Virus Expressing Human Immunodeficiency Virus 89.6 Envelope Protein Igor M. Belyakov, Linda S. Wyatt, Jeffrey D. Ahlers, Viral ReplicationImmunologyCd4 T Cell ResponsesImmunotherapyEnvelope Protein | 1998 | 109 |
1999 | 97 | |
1995 | 83 |
Page 1
Page 1